Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy
Gait analysis in 49 patients

References

• Arens L J, Goldschmidt R B, Leary P M. Botulinum toxin treatment in cerebral palsy: intervention with poor evalua-tion? Dev Med Child Neurol 1998; 40 (11): 785–7.
   PubMed Web of Science ®Google Scholar
• Bemben M G. Use of diagnostic ultrasound for assessing muscle size. J Strength Cond Res 2002; 16 (1): 103–8.
   PubMed Web of Science ®Google Scholar
• Boyd R N, Britton T C, Robinson R 0, Borzyskowski M. Transient urinary incontinence after botulinum A toxin. Lancet 1996; 348 (9025): 481–2.
   Google Scholar
• Boyd RN, Pliatsios V, Starr R, Wolfe R, Graham H K. Bio-mechanical transformation of the gastrocnemius-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol 2000; 42(1): 32–41.
   Google Scholar
• Chambers H, Lauer A, Kaufman K, Cardelia J M, Suther-land D. Prediction of outcome after rectus femoris surgery in cerebral palsy: the role of cocontraction of the rectus femoris and vastus lateralis. J Pediatr Orthop 1998; 18 (6): 703–11.
   Google Scholar
• Corry IS, Cosgrove A P, Duffy CM, McNeill S, Taylor T C, Graham H K. Botulinum toxin A compared with stretch-ing casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop 1998; 18 (3): 304–11.
   PubMed Web of Science ®Google Scholar
• Corry IS, Cosgrove A P, Duffy C M, Taylor T C, Graham H K. Botulinum toxin A in hamstring spasticity. Gait Pos-ture 1999; 10 (3): 206–10.
   PubMed Web of Science ®Google Scholar
• Cosgrove A P, Corry I S, Graham H K. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994; 36 (5): 386–96.
   PubMed Web of Science ®Google Scholar
• DeLuca P A, Ounpuu S, Davis R B, Walsh J H. Effect of hamstring and psoas lengthening on pelvic tilt in patients with spastic diplegic cerebral palsy. J Pediatr Orthop 1998; 18(6): 712–8.
   Google Scholar
• Eames NW, Baker R, Hill N, Graham K, Taylor T, Cosgrove A. The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Dev Med Child Neurol 1999; 41(4): 226–32.
   PubMed Web of Science ®Google Scholar
• Gage J R, DeLuca PA, Renshaw T S. Gait analysis: prin-ciple and applications with emphasis on its use in cerebral palsy. Instr Course Lect 1996; 45 (10): 491–507.
   Google Scholar
• Goldberg M J. Botulinum toxin type A improved ankle function in children with cerebral palsy and dynamic equinus foot deformity. J Bone Joint Surg (Am) 2000; 82 (6): 874.
   PubMedGoogle Scholar
• Kao I, Drachman D B, Price D L. Botulinum toxin: mecha-nism of presynaptic blockade. Science 1976; 193 (4259): 1256–8.
   PubMed Web of Science ®Google Scholar
• Koman LA, Mooney J F, ifi, Smith B, Goodman A, Mul-vaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 1993; 13 (4): 489–95.
   Google Scholar
• Koman LA, Mooney J F, III, Smith B P, Walker F, Leon J M. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000; 20 (1): 108–15.
   Google Scholar
• Koman LA, Brashear A, Rosenfeld S, et al. Botulinum toxin type A neuromuscular blockade in the treatment of equi-nus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics 2001; 108 (5): 1062–71.
   PubMed Web of Science ®Google Scholar
• McMulkin M L, Gulliford J J, Williamson R V, Ferguson R L. Correlation of static to dynamic measures of lower extremity range of motion in cerebral palsy and control populations. J Pediatr Orthop 2000; 20 (3): 366–9.
   PubMed Web of Science ®Google Scholar
• Metaxiotis D, Siebel A, Doederlein L. Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Clin Orthop 2002; 394: 177–85.
   Google Scholar
• Molenaers G, Desloovere K, De Cat J, et al. Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences. Eur J Neurol (Suppl 5) 2001; 8: 88–97.
   PubMed Web of Science ®Google Scholar
• Novacheck, T E Assessing Functional Outcomes. 1997. Connecticut Children's Medical Center, Hartford, Con-necticut, U.S.A. Clinical Gait Analysis. A Focus on Inter-pretation. Course Handout April 24, 1997.
   Google Scholar
• Novacheck T F, Stout J L, Tervo R. Reliability and validity of the Gillette Functional Assessment Questionnaire as an outcome measure in children with walking disabilities. J Pediatr Orthop 2000; 20(1): 75–81.
   PubMed Web of Science ®Google Scholar
• Papadonikolakis AS, Vekris M D, Kostas J P, Korompilias A V, Soucacos P N. Transient erectile dysfunction asso-ciated with botulinum type A intramuscular injection. J South Orthop Assoc 2002; 11 (2):116–88.
   PubMedGoogle Scholar
• Sampaio C, Ferreira J J, Simoes F, et al. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and toler-ability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1. Mov Disord 1997; 12(6): 1013–8.
   PubMed Web of Science ®Google Scholar
• Sutherland D H, Kaufman KR, Wyatt M P, Chambers HG, Mubarak S J. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 1999; 10 (1): 1–9.
   Google Scholar
• Thompson N S, Baker R J, Cosgrove AP, Cony IS, Graham H K. Musculoskeletal modelling in determining the effect of botulinum toxin on the hamstrings of patients with crouch gait. Dev Med Child Neurol 1998; 40 (9): 622–5.
   PubMed Web of Science ®Google Scholar
• To E W, Ahuja AT, Ho W S, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hyper-trophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001; 54 (3): 197–200.
   PubMedGoogle Scholar
• Ubhi T, Bhakta B B, Ives H L, Allgar V, Roussounis S H. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000; 83 (6): 481–7.
   PubMed Web of Science ®Google Scholar
• Willenborg M J, Shill J S, Smith B P, Estrada R L, Castle J A, Koman L A. Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum A toxin injection in cerebral palsy. J. Pediatr Orthop 2002; 22 (2): 165–8.
   PubMed Web of Science ®Google Scholar
• Wissel J, Heinen F, Schenkel A, et al. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Neuropediatrics 1999; 30 (3): 120–4.
   PubMed Web of Science ®Google Scholar